Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer

Clinical trial NCT02566993 · COMPLETED

Trial details

NCT number: NCT02566993
Sponsor: PharmaMar
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Small-cell Lung Cancer

Start date: 2016-08-30
Primary completion: 2020-02-24
Enrollment: 613

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.